Ikarian Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-361,518
Closed -$430K 136
2022
Q3
$430K Sell
361,518
-60,821
-14% -$94.8K 0.21% 88
2022
Q2
$761K Sell
422,339
-350,000
-45% -$516K 0.32% 87
2022
Q1
$1.56M Sell
772,339
-340,330
-31% -$669K 0.47% 79
2021
Q4
$3.02M Hold
1,112,669
0.86% 50
2021
Q3
$4.96M Sell
1,112,669
-16,804
-1% -$80.9K 1.14% 65
2021
Q2
$6.55M Buy
1,129,473
+450,000
+66% +$2.64M 1.17% 55
2021
Q1
$4.77M Buy
679,473
+37,365
+6% +$251K 0.71% 121
2020
Q4
$3.08M Sell
642,108
-114,128
-15% -$577K 0.56% 128
2020
Q3
$4.41M Buy
756,236
+741,318
+4,969% +$4.44M 1.23% 72
2020
Q2
$101K Sell
14,918
-397,000
-96% -$3.01M 0.03% 154
2020
Q1
$2.62M Buy
+411,918
New +$3.3M 0.98% 87
2019
Q4
Hold
0
145

Other funds holding CLVS